Хлебные крошки
- Главная
-
Аналитика
-
Акции
Акции внутренные
Cue Health Inc. HLTH
$0.67
-$0.09 (-13.00%)
На 18:04, 12 мая 2023
+1 094.03%
Потенциал через год
Ранг: 3
Ключевые показатели
-
Marketcap
125203136.00000000
-
week52high
6.12
-
week52low
0.66
-
Revenue
483476000
-
P/E TTM
0
-
Beta
0.00000000
-
EPS
-1.18000000
-
Last Dividend
0.00000000
-
Next Earnings Date
10 мая 2023 г. в 20:00
Описание компании
Cue Health Inc., a healthcare technology company, designs and develops diagnostic platform for diagnostic tests for individuals, enterprises, healthcare providers and payors, and public health agencies. The company offers Cue Integrated Care platform comprising hardware and software components, such as Cue Health Monitoring System consisting of Cue Reader, a portable and reusable reader, Cue Cartridge, a single-use test cartridge, and Cue Wand, a sample collection wand; Cue Data and Innovation Layer, a solution with cloud-based data and analytics capability; Cue Virtual Care Delivery Apps, which include Cue Health App and Cue Enterprise Dashboard; and Cue Ecosystem Integrations and Apps, a solution that allows integrations with third-party applications and sensors. It also provides COVID-19 testing kits for the Cue Health Monitoring System The company was formerly known as Cue Inc and changed its name to Cue Health Inc. in December 2017. Cue Health Inc. was incorporated in 2010 and is headquartered in San Diego, California.
Рекомендации
аналитиков
Рекомендации аналитиков
| Grading company | New grade | Previous grade | Recommendation date |
|---|---|---|---|
| Morgan Stanley | Equal-Weight | Equal-Weight | 11 авг 2022 г. |
| Morgan Stanley | Equal-Weight | Equal-Weight | 12 мая 2022 г. |
| Morgan Stanley | Equal-Weight | Equal-Weight | 30 мар 2022 г. |
| Morgan Stanley | Equal-Weight | 19 окт 2021 г. | |
| Goldman Sachs | Buy | 19 окт 2021 г. | |
| Goldman Sachs | Buy | Buy | 21 окт 2022 г. |
| Cowen & Co. | Outperform | Outperform | 14 ноя 2022 г. |
Свежие комментарии
Свежие комментарии
Оставьте свой голос
Оставьте свой голос
Анонимное голосование
Будет ли рост российского рынка к концу года?
-
Да
87% -
Нет
12%
Проголосовал 8 человек
Новостная лента
компании
Insider Summary
Insider Summary
| Reporting Name | Acquistion/Disposition | Owned | Transacted | Transaction Date |
|---|---|---|---|---|
| Palsis Erica | D | 623733 | 39070 | 01 февр 2023 г. |
| Gallagher John E | D | 633785 | 12415 | 28 дек 2022 г. |
| Khattak Ayub K | D | 11999995 | 30248 | 27 дек 2022 г. |
| Sever Clint | D | 3914899 | 24748 | 27 дек 2022 г. |
| Sever Clint | D | 0 | 29269 | 08 дек 2022 г. |
| Sever Clint | D | 3939647 | 29269 | 08 дек 2022 г. |
| Sever Clint | A | 3968916 | 29269 | 08 дек 2022 г. |
| Sever Clint | D | 29269 | 24147 | 07 дек 2022 г. |
| Sever Clint | D | 3939647 | 24147 | 07 дек 2022 г. |
| Sever Clint | A | 3963794 | 24147 | 07 дек 2022 г. |
Новостная лента
Cue Health CEO on FDA emergency authorization for Covid at-home test
CNBC Television
19 ноя 2022 г. в 09:16
The FDA has granted emergency use authorization for Cue Health's rapid Covid test, making it the first molecular test for Covid-19 authorized for at-home use without a prescription. Ayub Khattak, Cue Health co-founder and CEO, joined "Squawk Box" on Monday to discuss.
Cue Health, Inc. (HLTH) Q3 2022 Earnings Call Transcript
Seeking Alpha
12 ноя 2022 г. в 20:54
Cue Health, Inc. (NASDAQ:HLTH ) Q3 2022 Earnings Conference Call November 9, 2022 4:30 PM ET Company Participants Lorna Williams - IR Ayub Khattak - Co-Founder, President, CEO & Chairman John Gallagher - CFO Conference Call Participants Neel Ram - Morgan Stanley David Delahunt - Goldman Sachs Mark Massaro - BTIG Steven Braun - Cowen Operator Good day, and thank you for standing by. Welcome to the Cue Health Third Quarter Earnings Conference Call.
Cue Health Inc. (HLTH) Reports Q3 Loss, Tops Revenue Estimates
Zacks Investment Research
09 ноя 2022 г. в 18:48
Cue Health Inc. (HLTH) delivered earnings and revenue surprises of 21.82% and 19.92%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?
Cue Health Inc. (HLTH) Upgraded to Buy: Here's Why
Zacks Investment Research
01 ноя 2022 г. в 13:34
Cue Health Inc. (HLTH) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
Cue Health Needs Success In Flu Diagnostic To Reignite Growth
Seeking Alpha
13 сент 2022 г. в 15:37
Cue Health went public in September 2021, raising approximately $200 million in an IPO. The firm provides a COVID-19 molecular test and related software platform and is pursuing additional diagnostic tests for wide use.